Literature DB >> 19674077

Erosion of telomeric single-stranded overhang in patients with aplastic anaemia carrying telomerase complex mutations.

R T Calado1, J A Regal, S Kajigaya, N S Young.   

Abstract

BACKGROUND: Loss-of-function mutations in telomerase complex genes reduce telomerase activity and shorten overall telomere length in leucocytes, and they can clinically manifest as bone marrow failure (aplastic anaemia and dyskeratosis congenita) and familial pulmonary fibrosis. Telomeres are constituted of double-stranded tandem TTAGGG repeats followed by a 3' G-rich single-stranded overhang, a crucial telomeric structural component responsible for the t-loop formation.
MATERIALS AND METHODS: We investigated the length of telomeric overhangs in 25 healthy individuals from 0 to 76 years of age, 16 patients with aplastic anaemia, and 13 immediate relatives using a non-denaturing in-gel method and the telomere-oligonucleotide ligation assay.
RESULTS: Telomeric overhang lengths were constant from birth to eighth decade of life in healthy subjects, in contrast to overall telomere length, which shortened with ageing. Most patients with marrow failure and a telomerase gene mutation showed marked erosion of telomeric overhang associated with critically short telomeres; in other aplastic patients with normal genotypes, normal overall telomere lengths and who responded to immunosuppressive therapy, telomeric overhangs were maintained.
CONCLUSIONS: Telomeric overhang erosion does not participate in physiological ageing but support a role for eroded telomeric overhangs and abnormal telomere structure in pathological shortening of telomeres, especially caused by loss-of-function telomerase mutations. Disrupted telomere structure caused by short telomeric overhangs may contribute to the mechanisms of abnormal haematopoietic compartment senescence and chromosomal instability in human bone marrow failure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19674077      PMCID: PMC6738339          DOI: 10.1111/j.1365-2362.2009.02209.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  9 in total

1.  Novel variants in Nordic patients referred for genetic testing of telomere-related disorders.

Authors:  Anna Norberg; Anna Rosén; Klas Raaschou-Jensen; Lars Kjeldsen; Jukka S Moilanen; Ylva Paulsson-Karlsson; Panagiotis Baliakas; Olli Lohi; Aymen Ahmed; Astrid O Kittang; Pär Larsson; Göran Roos; Sofie Degerman; Magnus Hultdin
Journal:  Eur J Hum Genet       Date:  2018-02-26       Impact factor: 4.246

2.  Telomere content measurement in human hematopoietic cells: Comparative analysis of qPCR and Flow-FISH techniques.

Authors:  Taylor Wand; Mike Fang; Christina Chen; Nathan Hardy; J Philip McCoy; Bogdan Dumitriu; Neal S Young; Angélique Biancotto
Journal:  Cytometry A       Date:  2016-09-22       Impact factor: 4.355

3.  Heterozygous RTEL1 variants in bone marrow failure and myeloid neoplasms.

Authors:  Judith C W Marsh; Fernanda Gutierrez-Rodrigues; James Cooper; Jie Jiang; Shreyans Gandhi; Sachiko Kajigaya; Xingmin Feng; Maria Del Pilar F Ibanez; Flávia S Donaires; João P Lopes da Silva; Zejuan Li; Soma Das; Maria Ibanez; Alexander E Smith; Nicholas Lea; Steven Best; Robin Ireland; Austin G Kulasekararaj; Donal P McLornan; Anthony Pagliuca; Isabelle Callebaut; Neal S Young; Rodrigo T Calado; Danielle M Townsley; Ghulam J Mufti
Journal:  Blood Adv       Date:  2018-01-04

4.  Collapse of telomere homeostasis in hematopoietic cells caused by heterozygous mutations in telomerase genes.

Authors:  Geraldine Aubert; Gabriela M Baerlocher; Irma Vulto; Steven S Poon; Peter M Lansdorp
Journal:  PLoS Genet       Date:  2012-05-17       Impact factor: 5.917

5.  The clinical and functional effects of TERT variants in myelodysplastic syndrome.

Authors:  Christopher R Reilly; Mikko Myllymäki; Robert Redd; Shilpa Padmanaban; Druha Karunakaran; Valerie Tesmer; Frederick D Tsai; Christopher J Gibson; Huma Q Rana; Liang Zhong; Wael Saber; Stephen R Spellman; Zhen-Huan Hu; Esther H Orr; Maxine M Chen; Immaculata De Vivo; Daniel J DeAngelo; Corey Cutler; Joseph H Antin; Donna Neuberg; Judy E Garber; Jayakrishnan Nandakumar; Suneet Agarwal; R Coleman Lindsley
Journal:  Blood       Date:  2021-09-09       Impact factor: 25.476

6.  Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomas.

Authors:  Yuwei Zhang; Rodrigo Calado; Mahadev Rao; Julie A Hong; Alan K Meeker; Bogdan Dumitriu; Scott Atay; Peter J McCormick; Susan H Garfield; Danny Wangsa; Hesed M Padilla-Nash; Sandra Burkett; Mary Zhang; Tricia F Kunst; Nathan R Peterson; Sichuan Xi; Suzanne Inchauste; Nasser K Altorki; Alan G Casson; David G Beer; Curtis C Harris; Thomas Ried; Neal S Young; David S Schrump
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

7.  Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis.

Authors:  Mohamed Ali Mosrati; Kerstin Willander; Ingrid Jakobsen Falk; Monica Hermanson; Martin Höglund; Dick Stockelberg; Yuan Wei; Kourosh Lotfi; Peter Söderkvist
Journal:  Oncotarget       Date:  2015-09-22

Review 8.  Chromosomal Instability in Acute Myeloid Leukemia.

Authors:  Mateus de Oliveira Lisboa; Paulo Roberto Slud Brofman; Ana Teresa Schmid-Braz; Aline Rangel-Pozzo; Sabine Mai
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639

9.  Involvement of SRSF11 in cell cycle-specific recruitment of telomerase to telomeres at nuclear speckles.

Authors:  Ji Hoon Lee; Sun Ah Jeong; Prabhat Khadka; Juyeong Hong; In Kwon Chung
Journal:  Nucleic Acids Res       Date:  2015-08-18       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.